News | August 03, 2022
Jubilant Pharmova gets 6 observations from USFDA for its facility at Roorkee
he US FDA has issued six observations pursuant to the completion of the audit.
he US FDA has issued six observations pursuant to the completion of the audit.
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
India imported medical devices worth Rs. 63,200 crore in 2021-22, up 41% from Rs. 44,708 crore in 2020-21
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Medicines, including insulin, to be available in 40 lower-income countries
The company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe.
Govt committed to supporting pharma companies with industry-friendly policies
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Subscribe To Our Newsletter & Stay Updated
